In 2030, the World Health Organization estimates more than 350 million people will be diagnosed with diabetes. Consequently, Metformin -the biguanide drug of choice orally administered for diabetes type II -is anticipated to see a spike in production.
passes through the body unchanged. Entering aquatic compartments, such as in sewage, it can be bacterially transformed to the dead-end transformation product Guanylurea.
Several studies (including this paper) have shown the presence of both Metformin (Met) and Guanylurea (Gua) in both sewage treatment plants and rivers. Sampling over one week (n =5) from a Southern German plant revealed very high average (AV) concentrations in influent (AVMet = 111,800 ng/L, AVGua = 1,300 ng/L) and effluent (AVMet = 4,800 ng/L, AVGua = 44,000 ng/L).
To provide a more complete picture of this process, a highly sensitive mass spectrometric method with direct injection was used for the measurement of Metformin and Guanylurea in drinking water, surface water and seawater. Limits of quantification (LOQ) ranging from 2-10 ng/L allowed for the detection of Metformin and Guanylurea in locations: Lake Constance (n = 11: AVMet = 102 ng/L, AVGua = 16 ng/L), river Elbe (n = 12: AVMet = 472 ng/L, AVGua = 9 ng/L), river Weser (n = 6: AVMet = 349 ng/L, AVGua = 137 ng/L) and for the first time in maritime North Sea water (n = 14: AVMet = 13 ng/L, AVGua = 11 ng/L). Lake Constance is used to abstract potable water which is further purified to be used as drinking water. A first screening of two tap water samples contained 2 ng/L and 61 ng/L of Metformin, respectively. The results of this study suggest that Metformin and Guanylurea could be distributed over a large fraction of the world's potable water sources and oceans. With no natural degradation processes, these compounds can be easily reintroduced to humans as they enter the food chain.
Introduction
The prevalence of diabetes and obesity has reached epidemic dimensions in the 21 th century. In 1995, an estimated 135 million people worldwide were impacted by diabetes (King et al., 1998) ; this value is predicted to reach 366 million by 2030, with the greatest increase in diagnoses coming from developing countries (Wild et al., 2004) .
For decades the orally administered biguanide Metformin (Table 1 ) has proven to be an effective and convenient pharmaceutical treatment of diabetes mellitus type II (Reitman and Schadt, 2007) . Typical dosages range from 0.5 to 2.5 g, with annual
European per person sales rates of 5.9-12.1 gram, making Metformin among the most widely produced pharmaceutical drugs worldwide (Oosterhuis et al., 2013; Schuster et al., 2008) . In 2011, Germany alone prescribed a total of 601 million defined daily doses (DDDs), an increase of 3.9 % compared to 578 million DDDs in the year 2010 (Schwabe and Paffrath, 2012) . Each DDD accounts for 2 g of pure biguanide, which scales to a total Metformin consumption of 1202 tons in Germany for the year 2011 (WHO, 2013) . This number continues to increase as Metformin is more frequently becoming the main active ingredient in combinatorial antidiabetic drugs (more than 110 million DDDs in Germany) (WHO, 2013) .
Metformin cannot be metabolized by the human body and passes through unmodified within urine and faeces (Bailey and Turner, 1996) . It can be bacterially transformed (mainly in sewage treatment plants (STPs)) to its' dead-end transformation product Guanylurea (see Table 1 ) (Trautwein and Kümmerer, 2011) .
• Lake Constance is the third largest lake in central Europe (571 km 2 surface area), belonging in parts to Austria, Switzerland, and Germany. It is an important drinking water source and is supplied by the river Rhine, in which past studies have detected downstream instances of both target compounds (Scheurer et al., 2012 (Scheurer et al., , 2009 ).
• The rivers Elbe and Weser are heavily impacted by large German cities such as Dresden, Hamburg and Bremen, with the estuaries of both rivers being connected to the German Bight.
• The 3 rd area is the coastal region of the German Bight and North Sea, up to 250 km offshore.
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The environmental sampling points were completed by a five day screening of 24h mixed STP influent and effluent samples from a Southern German STP (600.000 population equivalent, no advanced treatment techniques). Additionally, two tap water samples of the urban region of Stuttgart were taken, deriving their drinking water from Lake Constance after some treatment (filtration with pumice and quartz, flocculation with iron(III)chloride, oxidation with hydrogen peroxide, disinfection with ozone and chlorine)(ZVBWV, 2013).
Materials and Methods

Water sample collection
Flow rate dependent 24 hour mixed STP influent and effluent samples were obtained from the treatment plant AZV Breisgauer Bucht (600.000 population equivalent) in 
Sample filtration and preparation
After transport to laboratory all samples were pretreated for analysis. Samples from Lake Constance and Rhine River were filtered directly (0.45 µm Nylon filters ; Infochroma AG, Zug, Switzerland), whereas all other samples were cleaned-up with two consecutive filtering steps using first 1.6 µm glass microfiber filters (VWR International, Leuven, Belgium) followed by 0.45 µm cellulose nitrate filters (Sartorious, Göttingen, Germany). After filtration all samples were adjusted to pH 7 ± 0.1 with 1 molar NaOH or HCl (Merck Chemicals, Darmstadt, Germany) and again stored at -20°C until analysis. One mL of pH adjusted and filtered water sample was transferred to a HPLC vial. 10 µL of internal standard stock solution (100 ng/mL) were added. Analysis was performed by HPLC-MS/MS. Direct injection (DI) was used for all samples. STP influent and effluent samples were diluted 100 times before analysis.
Chemicals, standards and calibration solutions
LC-MS grade methanol (MeOH) was purchased from Scharlau Chemie SA (Sentmenat, Spain), ammonium formate from Fluka (Buchs, Switzerland, LC-MS grade). Mobile phases for HPLC were used without filtration. Water used as mobile phase was purified in an Elix Milli-Q system (Millipore Corp., Volketswil, Switzerland).
Standards: Metformin (1,1-dimethylbiguanide hydrochloride, 97% purity) and Guanylurea (amidinourea, 99% purity) were purchased from Aldrich, Switzerland.
The purity of Guanylurea was determined by 1 H-and 13 C-NMR spectroscopy (Bruker Avance II 400 IOCSP1 400 MHz NMR spectrometer, University of Bern, Department of Chemistry and Biochemistry, Switzerland). Metformin-d6 (isotopic purity ≥ 99%) was obtained from Alsachim, Illkirch, France.
A stock solution containing Metformin and Guanylurea at a concentration of 100 ng/ mL in MeOH was prepared. Working solutions of the standards from 50 -100 ng/mL 7 in MeOH/water 1:1 were prepared for tuning studies. Calibration standards were prepared by serial dilution of the mixed working solution using Evian® mineral water, resulting in individual concentrations of 0-2100 ng/L. The calibration standards in Evian® mineral water were freshly prepared for every new series of samples. For the determination of Metformin and Guanylurea in seawater, matrix-matched standards were prepared, exhibiting a concentration range of 2-100 ng/L. An internal standard spike solution at a concentration of 100 ng/mL in MeOH was prepared. In sample volumes of 1.0 mL, 10 µL of the internal standard spike solution were added, resulting in a final concentration of 1000 ng/L.
HPLC and MS/MS conditions
A high-performance liquid chromatography Agilent 1260 system (Agilent Technologies, Wilmington, USA) equipped with a binary pump, a column oven thermostat operated at 50 0 C, a high performance well-plate autosampler with integrated needle wash (1 wash for 30s with a water/methanol 4:1 solution) and cooling option to keep the HPLC vials at constant temperature (15 0 C) was used.
Chromatography was performed on a XBridge Phenyl column, carbon load 15%, pore diameter 130 Å,150 mm x 2.1 mm, 3.5 µm particle size (Waters Corporation, Milford, Ma, USA), protected with a XBridge Phenyl guard cartridge 2.1 x 10 mm, 3.5 µm. Separation was achieved with a binary mobile phase at a flow rate of 100 µL/min. The eluent flow of the first 4.5 min as well as the reconditioning period of the chromatographic run was sent to waste via a 10 port-2-position valve installed postcolumn in order to prevent the ion source from contamination with matrix components. The optimized separation conditions were as follows: solvent A: water with 5 mM ammonium formate, solvent B: MeOH 100% with 5 mM ammonium formate. The gradient elution was as follows: 0 -4.5 min: 95% A, the organic phase B was increased to 95% within 4 min. After that, the column was cleaned with 95% 8 mobile Phase B for 1 min. Re-equilibration with 5% B took 6 min. The sample volume injected was 100 µL except for seawater (50 µl).
The HPLC was coupled to an API 5500 Qtrap mass spectrometer (AB Sciex, Concord, ON, Canada) with an electrospray Turbo V ionization source working in the positive ionization (ESI + ) mode. Acquisition was performed in the scheduled selective reaction monitoring mode (sSRM) and the protonated ion [M+H] + chosen as a precursor. Source parameters were optimized to the following final conditions: ion spray voltage: 4.5 kV (IS), collision gas: medium (CAD), curtain gas: 172 kPa (CUR), ion source gas 1: 310 kPa (GS 1, nebulizer gas), ion source gas 2: 448 kPa (GS 2, turbo gas) and ion source temperature: 550 0 C (TEMP). High purity nitrogen (> 98%) was used as desolvation, nebulizer and collision gas. Optimization of MS/MS parameters was performed by direct infusion at 10 µL/min flow rate of 50 to 100 ng/ mL of individual standard solutions. Declustering potential (DP), entrance potential (EP), collision energy (CE) and cell exit potential (CXP) voltages were established for each analyte and are summarized in Table 1 . Data were acquired and processed using the instrument software Analyst 1.6.1 (Applied Biosystems). 
Results and discussion
Method performance and quality assurance (QC)
Under the applied chromatographic conditions, Metformin eluted at a retention time of trMet = 6.6 min and Guanylurea at trGua = 5.7 min with base line separation. Method performance was evaluated through calculation of linearity, sensitivity, recovery and precision. Results are summarized in Table 2 . Quantitation based on peak areas was performed using the internal standard (IS) method. For Metformin, a corresponding deutererated analogue was used, whereas Guanylurea was quantified using external standard quantitation (no internal standard was available). Generally, a five point calibration curve was established by spiking milli-Q water with the analytes at a concentration ranging from 2-100 ng/L for drinking water and seawater, 5-1000 ng/L for lake and surface water and 0-2100 ng/L for 100 times diluted waste water samples. For quantitation of seawater, matrix matched calibration was performed in the NS6 sample (see Table 6 ). 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 10 Calibration curves were obtained for both transitions (T1, T2) and were linear with coefficients of determination R 2 ≥ 0.999. Quantitative results obtained by the T2 transistion regression line were normally within 10% of the T1 linear regression quantitation.
The LOQs for the target analytes were set to the lowest calibration standard. The calculation of the signal to noise (S/N) ratio at the LOQ was ≥ 9 for both compounds.
Recoveries (R) were quantitative for Metformin in all matrices and for Guanylurea in sea water and waste water. Lower recoveries were obtained for Guanylurea in surface, lake and drinking water samples (R = 39% -53%). This is in accordance with Scheurer et al. (2012) who found Guanylurea recoveries of 83% in drinking water and 65% in river water.
Environmental detection of low abundant xenobiotics like drugs, usually requires different clean-up and up-concentration techniques in order to be able to measure concentrations in the ng/L range.
A previous study for the detection of Metformin and Guanylurea in sewage treatment, surface water and drinking water used solid phase extraction (SPE) as method of choice and reached LOQs of 10 ng/L for Metformin and 50 ng/L for Guanylurea, respectively (Scheurer et al., 2012 ).
The analytical method described within this paper improved these thresholds by 5-fold, with no enrichment technique. At the same time, direct injection has several strong advantages: no enrichment of matrix or contaminations, no manipulation of samples and economization in time and money for sample preparation. When additionally the first minutes of the chromatographic run (solvent and matrix front) are sent to waste, lifetime of the analytical column can be extended and the mass spectrometer protected from contamination. 
Transformation rates of Metformin to Guanylurea in sewage treatment
As expected, STP samples contained the highest concentrations of both analytes ( Fig. 1) with Metformin dominating in the influent (86-142 µg/L) and Guanylurea in the effluent (28-67 µg/L).
Ratios of Metformin/Guanylurea ranged from 43 to 166 in the influent, whereas effluent ratios were inversely related and ranged from 0.08 to 0.18 (Supp. Table 1 ).
The high abundance of Guanylurea in effluent samples demonstrates the strong degree of Metformin transformation in STPs with elimination rates between 93% and 97% (Supp. Table 1 ).
The microbiological transformation of Metformin into Guanylurea was shown by Trautwein and Kümmerer (2011) 
Metformin and Guanylurea in Lake Constance and potable water
As to be expected, the concentrations of both target compounds were lower by a factor of around 1000 in surface water compared to STP effluent, which is known for other pharmaceuticals too (Kümmerer, 2008) . The detected Metformin concentrations in Lake Constance water samples range from 35 to 150 ng/L, whereas Guanylurea exhibited concentrations ranging from 10 to 22 ng/L (Table 3 ).
In the upper Rhine River, Metformin concentrations of up to 220 ng/L were found with lower amounts of Guanylurea (up to 100 ng/L). These concentrations are similar to Lake Constance is an important drinking water supply for large parts of Southern Germany and also Switzerland. Its main tributary is the river Rhine, one of the largest streams in Europe. The Rhine valley is densely populated -even upstream to Lake Constance -and thus human impact on the water quality of this lake is expected to be high. A recent multi-level approach for the integrated assessment of polar organic micropollutants (MP) within the catchment area of Lake Constance revealed 252 compounds to be of interest (Moschet et al., 2013) 4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 14 (surface until 1 m depth) of Lake Constance were halved compared to the hypolimnion (20 m -230 m depending on the spot) values.
In our study we detected both Metformin as well as Guanylurea in nearly all sampling spots with maximum concentrations of 150 ng/L (Metformin, Centre Lake) and 27 ng/L (Guanylurea, Rhine tributary) (Table 3) . Samples LC2 and LC4-LC6 were taken directly at the riverside of Lake Constance during a rainy day, so that dilution may have influenced the analytical results. At sampling point LC6 (Sipplingen), we detected 83 ng/L Metformin and 10 ng/L Guanylurea. This spot is of special interest since it is exactly at this location where the Lake Constance drinking water works retrieve their raw water (annually approximately 25 million m 3 serving four million citizens) (ZVBWV, 2013) . Consequently, two tap water samples from Filderstadt (urban region of Stuttgart), with drinking water from Lake Constance, showed 2 ng/L and 61 ng/L of Metformin, but no trace of Guanylurea. 
Distribution of Metformin and Guanylurea in North Sea tributaries
The German rivers Elbe and Weser are the two main tributaries of the German Bight and North Sea. Whereas no pharmaceutical contamination of the Weser has been reported to date, the river Elbe and its tributaries have been subject of extensive screening programs (Wiegel et al., 2004) . At sampling points close to the estuary of the Elbe into the North Sea, several prominent pharmaceuticals have been detected: Clofibric acid 4-18 ng/L, Diclofenac 3-8 ng/L and Ibuprofen 0.6 ng/L (Weigel et al., 2002; Wiegel et al., 2004) . The analytical results of this study for both target compounds are orders of magnitude higher (river Elbe: AVMet = 472 ng/L, AVGua = 23 ng/L, river Weser: AVMet = 349 ng/L, AVGua = 274 ng/L). Scheurer et al. (2009) detected at one countryside sampling point on the river Elbe, concentrations of Metformin of 1700 ng/L. This value is about three times higher than the findings of this study (Table 4) , however can be explained by influence of local STP effluents and smaller dilution factors than the estuary region.
The highest recorded concentrations of Metformin and Guanylrurea in the Elbe occurred at sampling point EW3, located at the end of the Hamburg urban area (Table 4 and Fig. 3) . Beyond point EW3, concentrations decrease slightly.
Elimination by sorption to suspended particulate matter or volatilisation into the atmosphere can be ignored because of the physical and chemical properties of Metformin. To verify the dilution by seawater, hypothetic Metformin concentrations were calculated from the salinity gradient (Guanylurea was excluded since it was only detected in half of all sampling points). The results are shown in Fig. 3 . This work reports the first ever evidence of pharmaceuticals occurring in the Weser River, which is a critical watershed for Northern Germany. In general, Metformin concentrations in the Weser River were lower but similar to the Elbe River (Fig. 4,   Table 4 ). A noticeable difference between these two rivers was identified for Guanylurea which was detected at three Weser sampling points (EW14, EW16 & EW18) with concentrations exceeding 200 ng/L (Table 4) . These findings are 17 unexpected, since at sampling points EW15, EW17 and EW19 no Guanylurea was detected. A check of the instruments raw data and repetition of measurement didn't reveal any analytical inconsistencies. One explanation for this discrepancy is dilution changes from changing tides during sampling. Further investigations are necessary for verification. Because of the specific usage of Metformin as long-term daily treatment drug, the assumption of a daily constant discharge was done. The mass flux estimations are based on the sampling points EW8 for Elbe and EW17 for Weser. These are the last sampling points upstream salt water influences. Daily mass fluxes were calculated by multiplication of concentrations with daily water discharge (Table 5 ). (Bollmann et al., 2012) and benzotriazoles 7 t/a (Wolschke et al., 2011) were estimated.
Metformin and Guanylurea in the marine environment
Whereas the distribution of pharmaceuticals in STPs, lakes and rivers has been extensively studied in the past (Kolpin et al., 2002; Ternes, 1998) The main current conditions of the investigated coastline are dominated by the eastern current of the "Continental Costal Water" (Turrell, 1992) . This current flows from the English Channel along the Dutch coast, the East Frisian Islands to the North Frisian Islands. The water masses in front of the East Frisian Islands (sampling points NS 1,6 and 7) are mainly contaminated from discharges of the Rhine and Scheldt River (Ahrens et al., 2009 ). This can be an indication for the high detected Guanylurea concentrations in that region. 
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Conclusions
• Metformin was firstly identified as a high-potential persistent environmental contaminant in 2006, because of its high prescription rate (Schuster et al., 2008) . Half of the total pharmaceutical load into STPs is expected to correspond to Metformin (KWR, STOWA, 2013) . The economic boom in many developing countries is often followed by the adoption of an obese western lifestyle, thus increasing strongly the prevalence of diabetes (Wild et al., 2004) . Metformin is a proven antidiabetic treatment and new pharmaceutical applications (e.g. against cancer (Leone et al., 2014) ) will increase prescriptions for Metformin even higher in the near future.
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• Laboratory biodegradation tests according to OECD guidelines revealed Guanylurea as bacterial dead-end transformation product (Trautwein and Kümmerer, 2011) , which was stable against common water treatment techniques like UV light irradiation and ozonation (Gartiser et al., 2011; Trautwein and Kümmerer, 2011) . Treatment with activated carbon which is the favored advanced treatment technique (no formation of TPs!) did not show consistent removal of both compounds (Scheurer et al., 2012) . Only chlorination with subsequent formation of TPs or riverbank filtration and groundwater recharge showed encouraging filtration results (Scheurer et al., 2012) . Since these techniques are not applied in wastewater treatment or drinking water preparation, huge amounts of Metformin and Guanylurea are released into and have been detected in various aquatic environments (Kolpin et al., 2002; Scheurer et al., 2012 Scheurer et al., , 2009 Vulliet and Cren-Olive, 2011 ).
• This study showed the presence of Metformin and Guanylurea in multiple fresh and salt water sources, where both compounds had not been detected injection provides a suitable tool for this task.
• First time detection of Metformin and Guanylurea in seawater and tap water demonstrates the absence any efficient degradation process in ocean 23 environments or drinking water preparation; which suggests high persistence and the potential for worldwide distribution.
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